What are TGTX's recent SEC filings?
TG Therapeutics issued a press release announcing its financial results for the three and nine months ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
View full filing details →TG Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including product revenue and license revenue. The filing contains standard quarterly financial statements and disclosures.
View full filing details →An institutional holder filed an amended Schedule 13G for TG Therapeutics, indicating a change in passive ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
View full filing details →Has TGTX ever done a stock split?
No stock splits are recorded for TGTX.
What is TGTX's share float?
Get Real-Time TGTX Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free